Z.AI and MiniMax: China’s Top AI Stocks Reveal Diverging Financial Health

China’s two premier publicly traded AI companies, Z.AI (2513.HK) and MiniMax Group (0100.HK), are navigating the turbulent market for high-growth tech stocks, characterized by soaring revenues and substantial losses. While both firms are expanding at a rapid pace, a closer look at their financial statements reveals diverging paths in profitability, balance sheet strength, and valuation, according to an analysis by Investing.com.

Revenue Soars, But Margins Tell Different Stories

Both companies are posting revenue growth that far outpaces most sectors, but their underlying profitability metrics are moving in opposite directions. MiniMax is projected to achieve faster revenue growth, while Z.AI currently commands a higher gross margin.

Key fiscal year 2025 projections highlight the contrast:

• Revenue Growth (FY23-FY25): MiniMax leads with an estimated 22.7x increase, compared to Z.AI's 11.8x.
• Gross Margin (FY25): Z.AI's margin is higher at 41.0%, but this represents a compression from 66% in 2023, signaling that rising compute costs may be outpacing its pricing power. MiniMax’s margin is lower at 25.4% but is improving from negative territory in 2023, suggesting its infrastructure is becoming more efficient.
• Net Income (FY25): Both remain deeply unprofitable, with Z.AI forecasting a net loss of HKD 2.14 billion and MiniMax a significantly larger loss of HKD 14.57 billion.

A Stark Divide in Financial Health and Valuation

Ad

MiniMax Group holds a distinct advantage in its financial stability. The company maintains a nearly debt-free balance sheet, with a debt-to-equity ratio of just 10.2% and a strong current ratio of 3.9x, indicating ample liquidity to sustain its operational losses. In contrast, Z.AI carries more leverage with a debt-to-equity ratio of 59.0% and a lower current ratio of 2.1x.

This difference is reflected in their valuation multiples. Z.AI trades at a lofty price-to-book ratio of 70.2x, pricing in near-perfect future execution. MiniMax’s P/B ratio is a more modest, though still high, 10.0x. Quantitative fair-value models cited by Investing.com suggest both stocks are overvalued, indicating a 37.2% potential downside for Z.AI and a 25.9% downside for MiniMax from their September 21 trading prices.

Conflicting Signals for Investors

The market is weighing Z.AI's stronger revenue momentum against MiniMax's superior financial hygiene. Analysts remain bullish on both, with firms like Bernstein and Macquarie setting price targets for Z.AI that imply over 100% upside, betting on the company's ability to convert its rapidly growing Annual Recurring Revenue (ARR) into profitable contracts.

For investors, the choice represents a classic growth-versus-value dilemma. Z.AI offers exposure to the fastest-growing Chinese AI lab by ARR, backed by strong institutional conviction. MiniMax presents a case built on improving unit economics, a robust balance sheet, and a valuation that has already seen significant risk priced out, with its stock trading more than 78% below its post-IPO high.